Introduction
Heart failure (HF) is a clinical syndrome characterized by non-specific symptoms and signs. 1 Left ventricular ejection fraction (LVEF) is typically used by most clinical trials, as defined by clinical guidelines, to classify HF patients into HF with reduced LVEF <40% (HFrEF) and preserved LVEF > _50% (HFpEF). 1, 2 Despite the lack of robust prognostic or pathophysiological data advocating a suitable cut-off for
The proposed diagnostic criteria of HFmrEF are parallel to those for HFpEF including elevated natriuretic peptides, evidence of diastolic dysfunction (DD), and structural changes such as left atrial (LA) enlargement and/or left ventricular (LV) hypertrophy (LVH). 1 LV DD is considered the primary pathology in HFpEF patients and perhaps HFmrEF determined by current conventional echocardiographic measures. 1, 8 LA function has a close interconnection with LV function and is divided into three phases, LA reservoir, conduit, and pump function, all of which contribute to LV filling. 9, 10 Conversely, LV function influences LA function. LA reservoir function is affected by LV contraction as LV base descends during systole, as well as LA compliance, and the transmission of right ventricular systolic pressure via the pulmonary circulation. 9 LA pump function is influenced by LV end-diastolic pressure, LV compliance, and LA contractile properties, while LA conduit function is dependent on LV diastolic properties. 9 As LV dysfunction progresses, the LA contribution to LV filling decreases, which may be attributed to intrinsic LA dysfunction caused by increased workload of the LA myocardium. 11 Indeed, previous studies comparing HFrEF and HFpEF phenotypes found greater impairment in LA phasic function in HFrEF. 12, 13 In clinical practice, LA function can be assessed by 2D-echocardiography, analysis of pulmonary venous and transmitral flows by Doppler echocardiography, and LA myocardial velocities by tissueDoppler echocardiography. However, its comprehensive quantification remains a challenge. 10 Assessment of LA phasic function using 2D-speckle-tracking echocardiography (2D-STE) has gained considerable attention due to its high feasibility and reproducibility [14] [15] [16] and has led to the early detection of LA impairment in a number of conditions including HF. 10 Recently, it has been proposed that LA dysfunction assessed by 2D-STE may play an important role in the pathophysiology of HFpEF [17] [18] [19] [20] [21] and that LA deformation using 2D-STE predicts adverse events in the general population, 22 and in HFpEF. 23, 24 In contrast, LA function in HFmrEF has not been previously investigated, and whether LA phasic function differs between HFmrEF and HFpEF is unknown. We, therefore, hypothesized that LA function is abnormal in HF patients and worse in HFmrEF patients than in those with HFpEF. To test this hypothesis, we evaluated LA phasic function using 2D-STE in consecutive HFmrEF and HFpEF patients.
Methods

Study population
Consecutive outpatients from HF clinics fulfilling current HF recommendations 1 were prospectively enrolled between January and May 2017. All patients were in optimal medical treatment and were haemodynamically stable. 
Echocardiographic acquisition and analyses
All patients underwent a comprehensive transthoracicechocardiographic examination in the left-lateral decubitus position using commercially available equipment (Phillips iE33, GE Vivid-7 or Vivid-E9 ultrasound systems). Images and loops were stored electronically (ProSolv cardiovascular, Fujifilm, Indianapolis, IN, USA) for offline analysis. Standard 2D-and Doppler-echocardiographic measurements were performed following ASE/EACVI guidelines. 8, 25 LV volumes and LVEF was calculated using the modified biplane Simpson's rule. 25 LV dimensions and wall thicknesses were measured during diastole from which LV mass index (LVMi) was calculated and indexed to body surface area (BSA). 25 Relative wall thickness (RWT) and LV geometry were defined according to standardized methodologies. 25 Maximum LA volume indexed (LAVi)
to BSA was calculated by the biplane method of discs at end-systole with LA remodelling (enlargement) defined as LAVi >34 mL/m 2 . 25 Minimum LA volume at QRS complex and pre-A LA volume preceding the P-wave were also calculated to assess LA phasic function by the volumetric method as follows 26 
:
LA total emptying fraction ðreservoir functionÞ = ½ðLA volume max -LA volume min Þ=LA volume max Â 100;
LA passive emptying fraction ðconduit functionÞ = ½ðLA volume max -LA volume pre-A Þ=LA volume max Â 100;
LA active emptying fraction ðpump functionÞ = ½ðLA volume pre-A -LA volume min Þ=LA volume pre-A Â 100:
LV diastolic function was evaluated in accordance with the current ASE/EACVI guidelines. 8 This included mitral inflow [early (E-wave) and late (A-wave) diastolic filling velocities, E/A ratio, and deceleration time (DT)], tissue-Doppler analysis of lateral mitral annular velocities (e 0 , a 0 , and s 0 ) from which E/e 0 ratio was calculated, and Doppler derivedpulmonary artery systolic pressure (PASP) was estimated from the peak tricuspid regurgitation (TR) velocity jet. The following parameters were used to determine the DD grade in HF patients as recommended: mitral inflow velocities, TR velocity jet >2.8 m/s, LAVi >34 mL/m 2 , lateral mitral annular e 0 velocity <10 cm/s, and lateral E/e 0 ratio >13. 8 LA phasic function was also assessed using 2D-STE. 10, [14] [15] [16] [27] [28] [29] The analysis was performed by a single investigator using vendor-independent acoustic-tracking software (TomTec Imaging Systems GMBH, Munich, Germany). LA endocardial borders were manually traced in nonforeshortened apical four-and two-chamber views with a frame rate of 60-80 frames per second 14 29 The software divided the LA into six segments to generate the LA strain curves and a total of 12-LA segments were obtained. The resulting tracking quality was evaluated in both views and manual adjustment was performed when necessary. Participants with significant foreshortened images of LA cavity or >2 non-visible LA segments were excluded as being unsuitable for LA 2D-STE analysis. LA strain measures were as follows ( Figure 1 ): (i) peak-atrial longitudinal strain (PALS) measured during ventricular systole reflecting LA reservoir function, (ii) peakatrial contraction strain (PACS) measured from the onset of P-wave prior to atrial contraction reflecting LA pump function, and (iii) the difference between PALS and PACS (PALS-PACS) reflecting LA conduit function. 14, 15, 30 Global PALS and PACS were calculated by averaging the strain values of all LA segments. 14, 15, 30 Intraobserver and interobserver variability were assessed for LA strain measures. The coefficient of variation (CV), intraclass correlation coefficient (ICC), and Bland-Altman limits of agreement showed overall good agreement [intraobserver variability, the CV was 7.6% for PALS, 13.3% for PACS, and 10.5% for PLAS-PACS, the ICC was 0.97 (0.95-1.0) for PALS, 0.91 (0.83-0.99) for PACS, and 0.97 (0.95-1.0) for PALS-PACS, and the mean difference was 0.39 (-4.2 to 4.9) for PALS, 0.35 (-3.2 to 3.9) for PACS, and 0.74 (-2.8 to 4.3) for PALS-PACS; interobserver variability, the CV was 12.0% for PALS, 15.1% for PACS, and 12.3% for PALS-PACS, the ICC was 0.86 (0.69-1.0) for PALS, 0.89 (0.76-1.0) for PACS, and 0.93 (0.85-1.0) for PALS-PACS, and the mean difference was 0.23 (-5.2 to 5.7) for PALS, 0.81 (-2.7 to 4.3) for PACS, and 1.0 (-1.7 to 3.7) for PALS-PACS].
Statistical methods
Continuous variables are presented as mean ± standard deviation (SD) or median (interquartile range) as appropriate. Categorical variables are presented as counts and percentages. Differences between groups were assessed using two-sample t-test with unequal variance or MannWhitney test for continuous variables and the v 2 test or Fisher's exact test for categorical variables. One way analysis of variance (ANOVA) with a post hoc test (pairwise comparison) was used for comparisons between more than two groups and the robust sandwich variance estimator was used when variance was heterogeneous between groups. Pearson or Spearman's rank tests were used for correlation analysis as appropriate. Multiple linear regression analysis was performed to compare LA strain measures between HF groups after adjustment for potential confounders (Model 1) or confounders plus possible mediators (Model 2) selected on a priori clinical-grounds [Model 1: age, sex, body mass index (BMI), heart rate, systolic blood pressure (SBP), DM, HTN, and IHD; Model 2: Model 1 plus LV end-diastolic volume index (LVEDVi), LVMi, LAVi, E/A, DT, E/e 0 , and S 0 ]. Regression diagnostics were performed to ensure the assumptions for multiple linear regression were satisfied.
We considered the possibility that LA function between HF groups might be modified by the DD grades and hence two-way ANOVA was performed. There was no evidence of a significant interaction between DD grades and HF groups for all LA strain measures (P > 0.05), so we concluded that DD grades did not modify the relationship between HF groups and LA strain measures (LA phasic function by DD grade are shown in Supplementary data online, Table S1 ). We also tested the possibility that LA function might be modified by remodelled LA (LAVi >34 mL/m 2 ). There was a significant interaction between LAVi >34 mL/ m 2 and HF groups, and hence results were presented stratified by LA size. A two-tailed P-value of <0.05 was considered statistically significant. All statistical analyses were performed using STATA software version 12.0 (StataCorp LLC, USA).
Results
Baseline clinical and echocardiographic characteristics
Baseline characteristics of the study population are summarized in Table 1 . All groups were similar in age, heart rate, and BMI. Females were more prevalent in the HFpEF group and controls. Brain natriuretic peptide (BNP) was similar in both HF groups and blood pressure was well controlled. Comorbidities characterized by history of HTN, DM, hypercholesterolaemia, renal, and IHD were similar in both HF groups except that HFpEF patients had a higher prevalence of renal disease. Of both HF groups, HFmrEF had higher LV volumes, mass and size, lower RWT, and more eccentric hypertrophy (19.5% vs. 8%), but less concentric remodelling or hypertrophy (34.5% vs. 62%) compared with HFpEF ( Table 1) . HFpEF patients had higher LV volumes, mass, and RWT when compared with controls. Compared to controls, maximal, and pre-A LA volumes were higher in both HF groups with no difference between them, whereas minimal LA volume was higher in HFmrEF than in HFpEF patients. LA enlargement (>34 mL/ m 2 ) was noted in 61% of HFmrEF and in 62% of HFpEF. Compared to controls, E/e 0 , TR velocity, and PASP were higher, and S 0 , e 0 , and a 0 were lower in both HF groups with no difference between them. The HFpEF group had higher transmitral flow velocities and DT compared with other groups, but E/A ratio and LV DD grades were similar in both HF groups.
LA function
LA reservoir function (global PALS and LA total emptying fraction), pump function (global PACS and LA active emptying fraction), and Figure 2 Comparison of LA phasic function between overall patients with HFmrEF, HFpEF, and controls assessed by volumetric method (A) and by 2D speckle-tracking echocardiography (B). Data are expressed as mean (95% confidence interval). HFmrEF, heart failure with mid-range ejection fraction; HFpEF, heart failure with preserved ejection fraction; LA, left atrial; PACS, peak-atrial contraction strain; PALS, peak-atrial longitudinal strain.
. conduit function (global PALS-PACS and LA passive emptying fraction) were impaired in both HF groups compared with controls, and were worse in HFmrEF patients than in HFpEF patients (Figures 2 and  3) . LA conduit function determined by LA passive emptying fraction was lower in the HFmrEF group than in the HFpEF group although the difference was not statistically significant. Among patients with LA enlargement, LA phasic function by 2D-STE remained lower in HFmrEF ( Figure 4A ). Even among patients with normal LA size (LAVi < _34 mL/m 2 ), LA reservoir and pump function were worse in HFmrEF ( Figure 4B ). Of HFpEF patients with normal LA size, LA reservoir and conduit, but not pump function were lower compared to controls.
Differences in LA reservoir, pump, and conduit function between HF groups were hardly altered and remained significant after adjustment for confounders including age, sex, BMI, heart rate, SBP, DM, HTN, and IHD. Further adjustment for LVEDVi, LVMi, LAVi, E/A, DT, E/e 0 , and S 0 also had negligible effects on differences (P < _ 0.001 for all) ( Table 2 ). Features of normal and HF (HFpEF and HFmrEF) hearts are summarized in Table 3 .
Correlates of LA strain measures
Worse global PALS and PACS were associated with higher BNP levels, LAVi, E/A ratio, LV filling pressure (E/e 0 ), and PASP, as well as worse DD grade in both HF groups (Table 4, Figure 5 ). Worse global PALS-PACS was only associated with higher LAVi and E/e 0 and greater DD grade in patients with HFpEF (Supplementary data online, Table S2 ).
Discussion
In this study, we looked at LA phasic function using 2D-STE in patients with HFmrEF in relation to those with HFpEF. We found that although both HF groups showed abnormal LA size and function overall, patients with HFmrEF had worse LA reservoir, conduit, and pump function than those with HFpEF while conventional echocardiographic measures of LA size and LV diastolic function were relatively similar. LA phasic function remained lower in HFmrEF patients regardless of LA size and after adjustment for multiple confounders or possible LV mediators. Further, differences in LA phasic function between both HF groups as assessed by 2D-STE were consistent with these obtained by the volumetric analysis. These findings indicate differences between the two HF categories, which could possibly be attributed to intrinsic LA myocardial dysfunction perhaps in relation to altered LV function. Previous studies have shown lower LA deformation indices assessed by tissue-Doppler imaging 13 and different LA remodelling by volumetric indices 12 in patients with HFrEF compared with those with HFpEF supporting that each of these HF categories represents distinct pathophysiological entities. 31 In our study, using 2D-STE, we extend those findings by showing that LA function assessed by 2D-STE as well as by volumetric indices remodelled differently in patients with HFmrEF compared with those with HFpEF supporting the hypothesis that HFmrEF and HFpEF represent different pathophysiological entities. Further, HFmrEF patients had greater degree of adverse LV remodelling as determined by lower LVEF, and higher LV volumes and mass highly indicating the close connection between LA and LV function. 11, 32 LA dysfunction in HFpEF has previously been described and it has been suggested that it may contribute to its pathophysiology. 12, [17] [18] [19] [20] [21] Santos et al. 18 found that impaired LA reservoir function determined by lower LA systolic strain was independent of LA size or remodelling secondary to atrial fibrillation in HFpEF patients. Likewise, we showed that all LA phasic functions were impaired in HF patients with a normal LA size except for LA pump function in HFpEF. This could be explained by a biphasic response: during the early stages of HF, LA pump function is increased to compensate for impaired LV filling in early diastole, but with more prolonged or severe HF LA contraction gradually deteriorates. 10, 28, 33 In contrast, LA pump and reservoir function were more impaired in HFmrEF patients, both in those with a normal LA size, and in the subset with a structurally remodelled LA (LAVi >34 mL/m 2 ). The reason why this is the case is unclear, and the cross-sectional nature of our data limits our ability to draw firm conclusions on this. Further LV dysfunction leads to increased LA afterload, which may lead to intrinsic LA myocardial dysfunction. 11, 13 However, LV filling pressure determined by E/e 0 was not different between the two HF groups. Additionally, increased LA wall tension through pressure overload caused by greater LVH may also contribute to LA dysfunction at least in part. 18 LA dysfunction varies according to the grade of LV DD. 34 Otani et al. 34 reported a progressive declined in LA reservoir and conduit function assessed by 2D-STE at advanced grades of DD, with initial augmentation of LA pump function in mild DD to allow adequate LV filling before being declined progressively in moderate to severe DD. In our study, we found a similar pattern that LA strains decreased progressively with higher grades of DD in both HF groups. Further, differences in LA phasic function between both HF groups was most prominent in the subset of patients with mild DD and decreased with advanced grades of DD.
Several studies suggest that DD and elevated filling pressure cannot completely account for LA dysfunction and that LA fibrosis may play an important role. 17, 20, 35 Indeed, global PALS and PACS showed only a moderate inverse correlation with diastolic function parameters presented in Table 3 in both HF groups. These results match those observed in earlier studies of HFpEF and extend them to HFmrEF patients. 17, 20, 21, 23, 34 Morris et al. 20 suggested that LA dysfunction in HFpEF is likely to be related to the same fibrotic process, which influences the LV subendocardial layer secondary to several comorbidities such as DM, HTN, and coronary artery disease. Our study showed that a number of multiple comorbidities were prevalent in both HF groups. Model 1: adjusted for age, sex, heart rate, systolic blood pressure, body mass index, diabetes mellitus, hypertension, and previous ischaemic heart disease. Model 2: Model 1 þ left ventricular (LV) end-diastolic volume index, LV mass index, left atrial volume index, early to late mitral inflow velocity ratio (E/A), deceleration time, E/e 0 ratio of early lateral mitral annular velocity (e 0 ) and S 0 . CI, confidence interval; HFmrEF, heart failure with mid-range ejection fraction; HFpEF, heart failure with preserved ejection fraction; PACS, peak-atrial contraction strain; PALS, peak-atrial longitudinal strain. . . . . . . . . . . . magnetic resonance imaging (MRI) algorithms is difficult clinically due to poor reproducibility, future studies in this population may be needed to correlate LA strain measures to the extent of LA fibrosis assessed by MRI. 36 BNP is a hormone secreted by atrial and ventricular myocytes in response to myocardial stress 37, 38 and is included in the diagnostic algorithm for HFmrEF and HFpEF. 1 Kurt et al. 37 showed that LA strains were inversely correlated with N-terminal pro-BNP, and lower LA BNP, brain natriuretic peptide; HFmrEF, heart failure with mid-range ejection fraction; HFpEF, heart failure with preserved ejection fraction; PACS, peak-atrial contraction strain; PALS, peak-atrial longitudinal strain. strains were noted in patients with LVEF <50% compared to those with normal LVEF. In this study, global PALS and PACS were lower in HFmrEF patients than in those with HFpEF, and worse global PALS and PACS correlated with higher BNP levels.
Limitations
A number of limitations of this study ought to be acknowledged. LA strain measurements require good delineation of LA endocardial borders. This resulted in the exclusion of a large number of patients from the analysis. Nevertheless, the reproducibility of measurements was good in the recruited patients. Although LA strain measures were obtained with the most widely used approach (onset of QRS complex), 29 some studies have used a different approach (onset of P-wave). Therefore, there is a need for standardizing methodology if this technique is to become clinically useful. The diagnosis of HFpEF and HFmrEF requires elevated natriuretic peptide levels; however, BNP measurements were not routinely performed in all patients, and were only available in 30% of HF patients. Despite that, we were able to show meaningful correlations between BNP and LA strain measures. Further, an invasive measurement of LV filling pressure was not obtained. Nevertheless, E/e 0 is an established non-invasive measure of LV filling pressure recommended by the ASE/EACVI guidelines. 8 An unresolved question is to what extent the observed difference in LA function is simply a consequence of worse LV systolic function in HFmrEF. Surprisingly, we observed no difference in S' between HFpEF and HFmrEF patients and adjustment for S' had minimal effects on differences between the two groups. LV global longitudinal strain might have provided more insight into this question but unfortunately it was not measured in this study. Finally, the study was cross-sectional and lacked follow-up. Therefore, the clinical implications of our findings should be studied further.
Conclusion
In summary, LA phasic function determined by 2D-STE was worse in patients with HFmrEF compared to those with HFpEF while conventional echocardiographic measures of LA size and LV diastolic function were similar. The greater impairment in LA phasic function in HFmrEF patients was regardless of LA size and independent of potential confounders or possible LV mediators. These differences could possibly be attributed to intrinsic LA myocardial dysfunction perhaps in relation to altered LV function. The prognostic and clinical values of LA dysfunction in HFmrEF patients remain to be determined.
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